Journal of Fungi (May 2021)

Invasive Fungal Infections in Persons Living with HIV in an Amazonian Context: French Guiana, 2009–2019

  • Laurène Cachera,
  • Antoine Adenis,
  • Basma Guarmit,
  • Sébastien Rabier,
  • Pierre Couppié,
  • Felix Djossou,
  • Loïc Epelboin,
  • Alessia Melzani,
  • Philippe Abboud,
  • Denis Blanchet,
  • Magalie Demar,
  • Kinan Drak Alsibai,
  • Mathieu Nacher

DOI
https://doi.org/10.3390/jof7060421
Journal volume & issue
Vol. 7, no. 6
p. 421

Abstract

Read online

Although the burden of histoplasmosis in patients with advanced HIV has been the focus of detailed estimations, knowledge about invasive fungal infections in patients living with HIV in an Amazonian context is somewhat scattered. Our goal was thus to adopt a broader view integrating all invasive fungal infections diagnosed over a decade in French Guiana. All patients hospitalized at Cayenne hospital from 1 January 2009 to 31 December 2018 with a proven diagnosis of invasive fungal infection were included (N = 227). Histoplasmosis was the most common (48.2%), followed by Cryptococcus infection (26.3%), and pneumocystosis (12.5%). For cryptococcal infection, there was a discordance between the actual diagnosis of cryptococcal meningitis n = (26) and the isolated presence of antigen in the serum (n = 46). Among the latter when the information was available (n = 34), 21(65.6%) were treated with antifungals but not coded as cryptococcocosis. Most fungal infections were simultaneous to the discovery of HIV (38%) and were the AIDS-defining event (66%). The proportion of major invasive fungal infections appeared to remain stable over the course of the study, with a clear predominance of documented H. capsulatum infections. Until now, the focus of attention has been histoplasmosis, but such attention should not overshadow other less-studied invasive fungal infections.

Keywords